• Print

MORU Publications 2010

(Click  to view online content)

 

  1. Ali S, Najmi MH, Tarning J, Lindegardh N. Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine. Malar J 2010;9:275. (Click) 
  2. Anderson TJ, Nair S, Nkhoma S, Williams JT, Imwong M, Yi P, et al. High heritability of malaria parasite clearance rate indicates a genetic basis for artemisinin resistance in western Cambodia. J Infect Dis 2010;201(9):1326-30.(Click) 
  3. Anderson TJ, Williams JT, Nair S, Sudimack D, Barends M, Jaidee A, et al. Inferred relatedness and heritability in malaria parasites. Proc Biol Sci 2010;277(1693):2531-40.(Click)
  4. Ashley EA, Stepniewska K, Lindegardh N, Annerberg A, Tarning J, McGready R, et al. Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria. Eur J Clin Pharmacol 2010;66(7):705-12.(Click) 
  5. Awab GR, Pukrittayakamee S, Imwong M, Dondorp AM, Woodrow CJ, Lee SJ, et al. Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial. Malar J 2010;9:105.(Click)
  6. Batra R, Cooper BS, Whiteley C, Patel AK, Wyncoll D, Edgeworth JD. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. Clin Infect Dis 2010;50(2):210-7.(Click) 
  7. Benner MT, Townsend J, Kaloi W, Htwe K, Naranichakul N, Hunnangkul S, et al. Reproductive health and quality of life of young Burmese refugees in Thailand. Confl Health 2010;4:5.(Click)
  8. Bethell D, Se Y, Lon C, Socheat D, Saunders D, Teja-Isavadharm P, et al. Dose-dependent risk of neutropenia after 7-day courses of artesunate monotherapy in Cambodian patients with acute Plasmodium falciparum malaria. Clin Infect Dis 2010;51(12):e105-14.(Click) 
  9. Blacksell SD, Jenjaroen K, Phetsouvanh R, Tanganuchitcharnchai A, Phouminh P, Phongmany S, et al. Accuracy of rapid IgM-based immunochromatographic and immunoblot assays for diagnosis of acute scrub typhus and murine typhus infections in Laos. Am J Trop Med Hyg 2010;83(2):365-9.(Click) 
  10. Blacksell SD, Jenjaroen K, Phetsouvanh R, Wuthiekanun V, Day NP, Newton PN, et al. Accuracy of AccessBio Immunoglobulin M and Total Antibody Rapid Immunochromatographic Assays for the Diagnosis of Acute Scrub Typhus Infection. Clin Vaccine Immunol 2010;17(2):263-6. (Click)
  11. Blessborn D, Romsing S, Bergqvist Y, Lindegardh N. Assay for screening for six antimalarial drugs and one metabolite using dried blood spot sampling, sequential extraction and ion-trap detection. Bioanalysis 2010;2(11):1839-47.(Click) 
  12. Boel M, Carrara VI, Rijken M, Proux S, Nacher M, Pimanpanarak M, et al. Complex Interactions between soil-transmitted helminths and malaria in pregnant women on the Thai-Burmese border. PLoS Negl Trop Dis 2010;4(11):e887.(Click)
  13. Bowers JR, Engelthaler DM, Ginther JL, Pearson T, Peacock SJ, Tuanyok A, et al. BurkDiff: a real-time PCR allelic discrimination assay for Burkholderia pseudomallei and B. mallei. PLoS One 2010;5(11):e15413.(Click) 
  14. Brouwer AE, Teparrukkul P, Rajanuwong A, Chierakul W, Mahavanakul W, Chantratita W, et al. Cerebrospinal fluid HIV-1 viral load during treatment of cryptococcal Meningitis. J Acquir Immune Defic Syndr 2010;53(5):668-9.(Click) 
  15. Buchanan J, Mihaylova B, Gray A, White N. Cost-effectiveness of pre-referral antimalarial, antibacterial, and combined rectal formulations for severe febrile illness. PLoS One 2010;5(12):e14446.(Click) 
  16. Burgoine KL, Bancone G, Nosten F. The reality of using primaquine. Malar J 2010;9:376.(Click)
  17. Chapman SJ, Khor CC, Vannberg FO, Rautanen A, Segal S, Moore CE, et al. NFKBIZ polymorphisms and susceptibility to pneumococcal disease in European and African populations. Genes Immun 2010;11(4):319-25.(Click) 
  18. Chapman SJ, Khor CC, Vannberg FO, Rautanen A, Walley A, Segal S, et al. Common NFKBIL2 polymorphisms and susceptibility to pneumococcal disease: a genetic association study. Crit Care 2010;14(6):R227.(Click)
  19. Chapman SJ, Vannberg FO, Khor CC, Rautanen A, Maskell NA, Davies CW, et al. Mannose-binding lectin genotypes: lack of association with susceptibility to thoracic empyema. BMC Med Genet 2010;11:5.(Click) 
  20. Cheah PY, Lwin KM, Phaiphun L, Parker M, Day N, White NJ, et al. Community engagement on the Thai-Burmese boeder rationale experience and lessons learnt. International Health 2010;2:123-9. 
  21. Choowongkomon K, Theppabutr S, Songtawee N, Day NP, White NJ, Woodrow CJ, et al. Computational analysis of binding between malarial dihydrofolate reductases and anti-folates. Malar J 2010;9:65.(Click)
  22. Chuangchaiya S, Jangpatarapongsa K, Chootong P, Sirichaisinthop J, Sattabongkot J, Pattanapanyasat K, et al. Immune response to Plasmodium vivax has a potential to reduce malaria severity. Clin Exp Immunol 2010;160(2):233-9.(Click) 
  23. Crawley J, Chu C, Mtove G, Nosten F. Malaria in children. Lancet 2010;375(9724):1468-81.(Click) 
  24. Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD, et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 2010;376(9753):1647-57.(Click) 
  25. Dondorp AM, Yeung S, White L, Nguon C, Day NP, Socheat D, et al. Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol 2010;8(4):272-80.(Click) 
  26. Douglas NM, Anstey NM, Angus BJ, Nosten F, Price RN. Artemisinin combination therapy for vivax malaria. Lancet Infect Dis 2010;10(6):405-16.(Click)
  27. Fried JR, Gibbons RV, Kalayanarooj S, Thomas SJ, Srikiatkhachorn A, Yoon IK, et al. Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006. PLoS Negl Trop Dis 2010;4(3):e617. (Click)
  28. Gaudin K, Millet P, Fawaz F, Olliaro P, White NJ, Cassus-Coussere C, et al. Investigation of porous graphitic carbon at high-temperature liquid chromatography with evaporative light scattering detection for the analysis of the drug combination artesunate--azithromycin for the treatment of severe malaria. J Chromatogr A 2010;1217(1):75-81.(Click) 
  29. Glover SJ, Maude RJ, Taylor TE, Molyneux ME, Beare NA. Malarial retinopathy and fluorescein angiography findings in a Malawian child with cerebral malaria. Lancet Infect Dis 2010;10(6):440.(Click) 
  30. Graves N, Harbarth S, Beyersmann J, Barnett A, Halton K, Cooper B. Estimating the cost of health care-associated infections: mind your p's and q's. Clin Infect Dis 2010;50(7):1017-21.(Click) 
  31. Halling-Brown M, Pappalardo F, Rapin N, Zhang P, Alemani D, Emerson A, et al. ImmunoGrid: towards agent-based simulations of the human immune system at a natural scale. Philos Transact A Math Phys Eng Sci 2010;368(1920):2799-815.(Click) 
  32. Hanson J, Lee SJ, Mohanty S, Faiz MA, Anstey NM, Charunwatthana P, et al. A simple score to predict the outcome of severe malaria in adults. Clin Infect Dis 2010;50(5):679-85.(Click)
  33. Harris SR, Feil EJ, Holden MT, Quail MA, Nickerson EK, Chantratita N, et al. Evolution of MRSA during hospital transmission and intercontinental spread. Science 2010;327(5964):469-74.(Click) 
  34. Hietala SF, Martensson A, Ngasala B, Dahlstrom S, Lindegardh N, Annerberg A, et al. Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania. Antimicrob Agents Chemother 2010;54(11):4780-8.(Click) 
  35. Imwong M, Dondorp AM, Nosten F, Yi P, Mungthin M, Hanchana S, et al. Exploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum. Antimicrob Agents Chemother 2010;54(7):2886-92.(Click)
  36. Inthavilay S, Franchard T, Meimei Y, Ashley EA, Barennes H. Knowledge and acceptability of the rectal treatment route in Laos and its application for pre-referral emergency malaria treatment. Malar J 2010;9:342.(Click)
  37. Izzard L, Fuller A, Blacksell SD, Paris DH, Richards AL, Aukkanit N, et al. Isolation of a novel Orientia species (O. chuto sp. nov.) from a patient infected in Dubai. J Clin Microbiol 2010;48(12):4404-9.(Click)
  38. Karema C, Imwong M, Fanello CI, Stepniewska K, Uwimana A, Nakeesathit S, et al. Molecular correlates of high-level antifolate resistance in Rwandan children with Plasmodium falciparum malaria. Antimicrob Agents Chemother 2010;54(1):477-83.(Click) 
  39. Kaur HH, D. Fernandez, F. Green, MD. Newton, PN. Antimalarial drug quality - methods to detect suspect drugs. Therapy 2010;7:49-57. 
  40. Khor CC, Vannberg FO, Chapman SJ, Guo H, Wong SH, Walley AJ, et al. CISH and susceptibility to infectious diseases. N Engl J Med 2010;362(22):2092-101.(Click) 
  41. Koh GC, Limmathurotsakul D. Gamma interferon supplementation for melioidosis. Antimicrob Agents Chemother 2010;54(10):4520; author reply 20-1.(Click) 
  42. Koh GC, Maude RJ, Paris DH, Newton PN, Blacksell SD. Diagnosis of scrub typhus. Am J Trop Med Hyg 2010;82(3):368-70.(Click) 
  43. Kumsiri R, Potup P, Chotivanich K, Petmitr S, Kalambaheti T, Maneerat Y. Blood stage Plasmodium falciparum antigens induce T cell independent immunoglobulin production via B cell activation factor of the TNF family (BAFF) pathway. Acta Trop 2010;116(3):217-26. (Click) 
  44. Kypraios T, O'Neill PD, Huang SS, Rifas-Shiman SL, Cooper BS. Assessing the role of undetected colonization and isolation precautions in reducing methicillin-resistant Staphylococcus aureus transmission in intensive care units. BMC Infect Dis 2010;10:29. (Click) 
  45. Lang TA, White NJ, Tran HT, Farrar JJ, Day NP, Fitzpatrick R, et al. Clinical research in resource-limited settings: enhancing research capacity and working together to make trials less complicated. PLoS Negl Trop Dis 2010;4(6):e619.(Click) 
  46. Lee N, Wong CK, Chan PK, Lindegardh N, White NJ, Hayden FG, et al. Acute encephalopathy associated with influenza A infection in adults. Emerg Infect Dis 2010;16(1):139-42.(Click) 
  47. Leelahavarong P, Chaikledkaew U, Hongeng S, Kasemsup V, Lubell Y, Teerawattananon Y. A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand. BMC Health Serv Res 2010;10:209.(Click) 
  48. Leimanis ML, Jaidee A, Sriprawat K, Kaewpongsri S, Suwanarusk R, Barends M, et al. Plasmodium vivax susceptibility to ferroquine. Antimicrob Agents Chemother 2010;54(5):2228-30.(Click) 
  49. Limmathurotsakul D, Jamsen K, Arayawichanont A, Simpson JA, White LJ, Lee SJ, et al. Defining the true sensitivity of culture for the diagnosis of melioidosis using Bayesian latent class models. PLoS One 2010;5(8):e12485.(Click) 
  50. Limmathurotsakul D, Wongratanacheewin S, Teerawattanasook N, Wongsuvan G, Chaisuksant S, Chetchotisakd P, et al. Increasing incidence of human melioidosis in Northeast Thailand. Am J Trop Med Hyg 2010;82(6):1113-7.(Click) 
  51. Limmathurotsakul D, Wuthiekanun V, Chantratita N, Wongsuvan G, Amornchai P, Day NP, et al. Burkholderia pseudomallei is spatially distributed in soil in northeast Thailand. PLoS Negl Trop Dis 2010;4(6):e694.(Click) 
  52. Lourens C, Watkins WM, Barnes KI, Sibley CH, Guerin PJ, White NJ, et al. Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN). Malar J 2010;9:375.(Click)
  53. Lowenberg EC, Charunwatthana P, Cohen S, van den Born BJ, Meijers JC, Yunus EB, et al. Severe malaria is associated with a deficiency of von Willebrand factor cleaving protease, ADAMTS13. Thromb Haemost 2010;103(1):181-7.(Click) 
  54. Lubell Y. Cost-effective use of prereferral treatment for severe malaria. Lancet 2010;376(9756):1880-1.(Click) 
  55. Lubell Y, Mills AJ, Whitty CJ, Staedke SG. An economic evaluation of home management of malaria in Uganda: an interactive Markov model. PLoS One 2010;5(8):e12439.(Click) 
  56. Maude RJ, Hassan MU, Ghose A, Douthwaite ST, Faiz MA, Dondorp AM. Studies on severe malaria are still possible and essential. Clin Infect Dis 2010;50(2):281-2.(Click)
  57. Maude RJ, Lubell Y, Socheat D, Yeung S, Saralamba S, Pongtavornpinyo W, et al. The role of mathematical modelling in guiding the science and economics of malaria elimination. Int Health 2010;2(4-6):239-46. (Click) 
  58. Maude RJ, Woodrow CJ, White LJ. Artemisinin Antimalarials: Preserving the "Magic Bullet". Drug Dev Res 2010;71(1):12-19.(Click) 
  59. Mayxay M, Keomany S, Khanthavong M, Souvannasing P, Stepniewska K, Khomthilath T, et al. A phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate-mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern Laos. Am J Trop Med Hyg 2010;83(6):1221-9.(Click)
  60. McGready R, Ashley EA, Wuthiekanun V, Tan SO, Pimanpanarak M, Viladpai-Nguen SJ, et al. Arthropod borne disease: the leading cause of fever in pregnancy on the Thai-Burmese border. PLoS Negl Trop Dis 2010;4(11):e888.(Click) 
  61. McGready R, Blacksell SD, Luksameetanasan R, Wuthiekanun V, Jedsadapanpong W, Day NP, et al. First report of an Orientia tsutsugamushi type TA716-related scrub typhus infection in Thailand. Vector Borne Zoonotic Dis 2010;10(2):191-3.(Click)
  62. McGready R, Wuthiekanun V, Ashley EA, Tan SO, Pimanpanarak M, Viladpai-Nguen SJ, et al. Diagnostic and treatment difficulties of pyelonephritis in pregnancy in resource-limited settings. Am J Trop Med Hyg 2010;83(6):1322-9.(Click) 
  63. Medana IM, Day NP, Roberts R, Sachanonta N, Turley H, Pongponratn E, et al. Induction of the vascular endothelial growth factor pathway in the brain of adults with fatal falciparum malaria is a non-specific response to severe disease. Histopathology 2010;57(2):282-94.(Click) 
  64. Miotto O, Heiny AT, Albrecht R, Garcia-Sastre A, Tan TW, August JT, et al. Complete-proteome mapping of human influenza A adaptive mutations: implications for human transmissibility of zoonotic strains. PLoS One 2010;5(2):e9025.(Click) 
  65. Monatrakul P, Mungthin M, Dondorp AM, Krudsood S, Udomsangpetch R, Wilairatana P, et al. Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum. Malar J 2010;9:326.(Click) 
  66. Moore CE, Sengduangphachanh A, Thaojaikong T, Sirisouk J, Foster D, Phetsouvanh R, et al. Enhanced determination of Streptococcus pneumoniae serotypes associated with invasive disease in Laos by using a real-time polymerase chain reaction serotyping assay with cerebrospinal fluid. Am J Trop Med Hyg 2010;83(3):451-7.(Click)
  67. Mu J, Myers RA, Jiang H, Liu S, Ricklefs S, Waisberg M, et al. Plasmodium falciparum genome-wide scans for positive selection, recombination hot spots and resistance to antimalarial drugs. Nat Genet 2010;42(3):268-71.(Click) 
  68. Muehlenbachs A, Fried M, McGready R, Harrington WE, Mutabingwa TK, Nosten F, et al. A novel histological grading scheme for placental malaria applied in areas of high and low malaria transmission. J Infect Dis 2010;202(10):1608-16.(Click)
  69. Mwesigwa J, Parikh S, McGee B, German P, Drysdale T, Kalyango JN, et al. Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda. Antimicrob Agents Chemother 2010;54(1):52-9.(Click) 
  70. Nair S, Nkhoma S, Nosten F, Mayxay M, French N, Whitworth J, et al. Genetic changes during laboratory propagation: copy number At the reticulocyte-binding protein 1 locus of Plasmodium falciparum. Mol Biochem Parasitol 2010;172(2):145-8.(Click) 
  71. Nakamura K, Schwartz BS, Lindegardh N, Keh C, Guglielmo BJ. Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection. Clin Infect Dis 2010;50(7):e47-9.(Click)
  72. Newton P. Leptospirosis. Lao Medical Journal 2010;1:14-22. 
  73. Newton PN, Green MD, Fernandez FM. Impact of poor-quality medicines in the 'developing' world. Trends Pharmacol Sci 2010;31(3):99-101.(Click) 
  74. Nosten FH. Pyronaridine-artesunate for uncomplicated falciparum malaria. Lancet 2010;375(9724):1413-4. (Click) 
  75. Okiro EA, White LJ, Ngama M, Cane PA, Medley GF, Nokes DJ. Duration of shedding of respiratory syncytial virus in a community study of Kenyan children. BMC Infect Dis 2010;10:15.(Click)
  76. Omodeo-Sale F, Cortelezzi L, Vommaro Z, Scaccabarozzi D, Dondorp AM. Dysregulation of L-arginine metabolism and bioavailability associated to free plasma heme. Am J Physiol Cell Physiol 2010;299(1):C148-54.(Click) 
  77. Pagnarith Y, Kumar V, Thaipadungpanit J, Wuthiekanun V, Amornchai P, Sin L, et al. Emergence of pediatric melioidosis in Siem Reap, Cambodia. Am J Trop Med Hyg 2010;82(6):1106-12.(Click) 
  78. Pattanapanyasat K, Sratongno P, Chimma P, Chitjamnongchai S, Polsrila K, Chotivanich K. Febrile temperature but not proinflammatory cytokines promotes phosphatidylserine expression on Plasmodium falciparum malaria-infected red blood cells during parasite maturation. Cytometry A 2010;77(6):515-23. (Click) 
  79. Phetsouvanh R. Rickettsial diseases. Lao Medical Journal 2010;1:23-8
  80. Phu NH, Tuan PQ, Day N, Mai NT, Chau TT, Chuong LV, et al. Randomized controlled trial of artesunate or artemether in Vietnamese adults with severe falciparum malaria. Malar J 2010;9:97.(Click)
  81. Piola P, Nabasumba C, Turyakira E, Dhorda M, Lindegardh N, Nyehangane D, et al. Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial. Lancet Infect Dis 2010;10(11):762-9. (Click)
  82. Preechapornkul P, Chotivanich K, Imwong M, Dondorp AM, Lee SJ, Day NP, et al. Optimizing the culture of Plasmodium falciparum in hollow fiber bioreactors. Southeast Asian J Trop Med Public Health 2010;41(4):761-9.(Click) 
  83. Price EP, Hornstra HM, Limmathurotsakul D, Max TL, Sarovich DS, Vogler AJ, et al. Within-host evolution of Burkholderia pseudomallei in four cases of acute melioidosis. PLoS Pathog 2010;6(1):e1000725.(Click) 
  84. Pukrittayakamee S, Imwong M, Chotivanich K, Singhasivanon P, Day NP, White NJ. A comparison of two short-course primaquine regimens for the treatment and radical cure of Plasmodium vivax malaria in Thailand. Am J Trop Med Hyg 2010;82(4):542-7.(Click) 
  85. Rahman W, Chotivanich K, Silamut K, Tanomsing N, Hossain A, Faiz MA, et al. Plasmodium malariae in Bangladesh. Trans R Soc Trop Med Hyg 2010;104(1):78-80.(Click)
  86. Ravinetto RM, L. White, NJ. . Ethical criteria in clinical research in developing  countries: is there a global standard ? The Italian Journal of Tropical Medicine 2010;15:1-4. 
  87. Rerknimitr R, Limmathurotsakul D, Bhokaisawan N, Kongkam P, Treeprasertsuk S, Kullavanijaya P. A comparison of diagnostic efficacies among different reagent strips and automated cell count in spontaneous bacterial peritonitis. J Gastroenterol Hepatol 2010;25(5):946-50.(Click) 
  88. Rottmann M, McNamara C, Yeung BK, Lee MC, Zou B, Russell B, et al. Spiroindolones, a potent compound class for the treatment of malaria. Science 2010;329(5996):1175-80.(Click) 
  89. Sim BM, Chantratita N, Ooi WF, Nandi T, Tewhey R, Wuthiekanun V, et al. Genomic acquisition of a capsular polysaccharide virulence cluster by non-pathogenic Burkholderia isolates. Genome Biol 2010;11(8):R89.(Click) 
  90. Smithuis F, Kyaw MK, Phe O, Win T, Aung PP, Oo AP, et al. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Lancet Infect Dis 2010;10(10):673-81.(Click) 
  91. Soepandi PZ, Burhan E, Mangunnegoro H, Nawas A, Aditama TY, Partakusuma L, et al. Clinical course of avian influenza A(H5N1) in patients at the Persahabatan Hospital, Jakarta, Indonesia, 2005-2008. Chest 2010;138(3):665-73.(Click) 
  92. Sonthayanon P, Peacock SJ, Chierakul W, Wuthiekanun V, Blacksell SD, Holden MT, et al. High rates of homologous recombination in the mite endosymbiont and opportunistic human pathogen Orientia tsutsugamushi. PLoS Negl Trop Dis 2010;4(7):e752.(Click) 
  93. Stepniewska K, Ashley E, Lee SJ, Anstey N, Barnes KI, Binh TQ, et al. In vivo parasitological measures of artemisinin susceptibility. J Infect Dis 2010;201(4):570-9.(Click)
  94. Suputtamongkol Y, Pongtavornpinyo W, Lubell Y, Suttinont C, Hoontrakul S, Phimda K, et al. Strategies for diagnosis and treatment of suspected leptospirosis: a cost-benefit analysis. PLoS Negl Trop Dis 2010;4(2):e610. (Click) 
  95. Sutherland CJ, Tanomsing N, Nolder D, Oguike M, Jennison C, Pukrittayakamee S, et al. Two nonrecombining sympatric forms of the human malaria parasite Plasmodium ovale occur globally. J Infect Dis 2010;201(10):1544-50.(Click)  
  96. Syhavong B, Rasachack B, Smythe L, Rolain JM, Roque-Afonso AM, Jenjaroen K, et al. The infective causes of hepatitis and jaundice amongst hospitalised patients in Vientiane, Laos. Trans R Soc Trop Med Hyg 2010;104(7):475-83.(Click) 
  97. Takeuchi R, Lawpoolsri S, Imwong M, Kobayashi J, Kaewkungwal J, Pukrittayakamee S, et al. Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border. Malar J 2010;9:308.(Click) 
  98. Tan PT, Heiny AT, Miotto O, Salmon J, Marques ET, Lemonnier F, et al. Conservation and diversity of influenza A H1N1 HLA-restricted T cell epitope candidates for epitope-based vaccines. PLoS One 2010;5(1):e8754.(Click) 
  99. Tandhavanant S, Thanwisai A, Limmathurotsakul D, Korbsrisate S, Day NP, Peacock SJ, et al. Effect of colony morphology variation of Burkholderia pseudomallei on intracellular survival and resistance to antimicrobial environments in human macrophages in vitro. BMC Microbiol 2010;10:303.(Click)
  100. Tanomsing N, Imwong M, Theppabutr S, Pukrittayakamee S, Day NP, White NJ, et al. Accurate and sensitive detection of Plasmodium species in humans by use of the dihydrofolate reductase-thymidylate synthase linker region. J Clin Microbiol 2010;48(10):3735-7.(Click) 
  101. Tantibhedhyangkul W, Angelakis E, Tongyoo N, Newton PN, Moore CE, Phetsouvanh R, et al. Intrinsic fluoroquinolone resistance in Orientia tsutsugamushi. Int J Antimicrob Agents 2010;35(4):338-41.(Click)
  102. Tricou V, Minh NN, Van TP, Lee SJ, Farrar J, Wills B, et al. A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults. PLoS Negl Trop Dis 2010;4(8):e785.(Click)
  103. Turner P, Turner CL, Watthanaworawit W, Carrara VI, Kapella BK, Painter J, et al. Influenza in refugees on the Thailand-Myanmar border, May-October 2009. Emerg Infect Dis 2010;16(9):1366-72.(Click) 
  104. Valecha N, Phyo AP, Mayxay M, Newton PN, Krudsood S, Keomany S, et al. An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia. PLoS One 2010;5(7):e11880.(Click) 
  105. Vallee J, Thaojaikong T, Moore CE, Phetsouvanh R, Richards AL, Souris M, et al. Contrasting spatial distribution and risk factors for past infection with scrub typhus and murine typhus in Vientiane City, Lao PDR. PLoS Negl Trop Dis 2010;4(12):e909.(Click) 
  106. van der Windt GJ, Hoogerwerf JJ, de Vos AF, Florquin S, van der Poll T. Osteopontin promotes host defense during Klebsiella pneumoniae-induced pneumonia. Eur Respir J 2010;36(6):1337-45.(Click) 
  107. Wertheim HF, Puthavathana P, Nghiem NM, van Doorn HR, Nguyen TV, Pham HV, et al. Laboratory capacity building in Asia for infectious disease research: experiences from the South East Asia Infectious Disease Clinical Research Network (SEAICRN). PLoS Med 2010;7(4):e1000231.(Click) 
  108. West TE, Myers ND, Limmathurotsakul D, Liggitt HD, Chantratita N, Peacock SJ, et al. Pathogenicity of high-dose enteral inoculation of Burkholderia pseudomallei to mice. Am J Trop Med Hyg 2010;83(5):1066-9.(Click)
  109. White LJ, Schukken YH, Dogan B, Green L, Dopfer D, Chappell MJ, et al. Modelling the dynamics of intramammary E. coli infections in dairy cows: understanding mechanisms that distinguish transient from persistent infections. Vet Res 2010;41(2):13. (Click) 
  110. White NJ. Artemisinin resistance--the clock is ticking. Lancet 2010;376(9758):2051-2.(Click)
  111. White NJ, Turner GD, Medana IM, Dondorp AM, Day NP. The murine cerebral malaria phenomenon. Trends Parasitol 2010;26(1):11-5.(Click) 
  112. Wiersinga WJ, Calandra T, Kager LM, van der Windt GJ, Roger T, le Roy D, et al. Expression and function of macrophage migration inhibitory factor (MIF) in melioidosis. PLoS Negl Trop Dis 2010;4(2):e605.(Click) 
  113. Wiersinga WJ, Kager LM, Hovius JW, van der Windt GJ, de Vos AF, Meijers JC, et al. Urokinase receptor is necessary for bacterial defense against pneumonia-derived septic melioidosis by facilitating phagocytosis. J Immunol 2010;184(6):3079-86.(Click) 
  114. Willemsen I, Cooper B, van Buitenen C, Winters M, Andriesse G, Kluytmans J. Improving quinolone use in hospitals by using a bundle of interventions in an interrupted time series analysis. Antimicrob Agents Chemother 2010;54(9):3763-9.(Click) 
  115. Woodrow CJ, Bustamante LY. Plasmodium falciparum ATP6 not under selection during introduction of artemisinin combination therapy in Peru. Antimicrob Agents Chemother 2010;54(5):2280; author reply 80-1.(Click)